Effects of neutral pH and reduced glucose degradation products in a new peritoneal dialysis solution on morphology of peritoneal membrane in rats

被引:7
|
作者
Ikehara, O
Nishimura, H
Naito, T
Higuchi, C
Sanaka, T
机构
[1] Shimizu Pharmaceut Co Ltd, CAPD Div, Dept Res & Dev, Shizuoka, Japan
[2] Tokyo Womens Med Univ, Daini Hosp Med Ctr, Dept Nephrol & Blood Purificat, Tokyo, Japan
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2005年 / 100卷 / 01期
关键词
biocompatibility of PD treatment; glucose degradation products; imprint; peritoneal dialysis solution; peritoneal membrane; pH;
D O I
10.1159/000084110
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In vitro studies have shown that pH and glucose degradation products (GDPs) in the dialysate are determinant factors for the biocompatibility of peritoneal dialysis (PD) treatment. The present study was thus designed to evaluate whether a newly developed PD solution, which features neutral pH levels and a low GDP concentration, influences tissue damage of the peritoneal membrane in an in vivo setting, and which factor is more critical to the histological changes. Methods: Rats were injected 3 times per day during 1 or 4 weeks with 10 ml of various PD fluids ( group G, acidic pH, high GDPs; group S, neutral pH, low GDPs; or group A, acidic pH, low GDPs). When the experimental period was over, the mesothelial cell monolayers of the animals were taken and studied with population analysis, and peritoneal membranes were obtained from the abdominal wall for immunohistochemical examination with proliferating cell nuclear antigen ( PCNA) and for measurement of thickness of the peritoneal specimens. Results: The density of the mesothelial cell monolayer and the number of fibroblast-like cells in group S were significantly less than in group G at 1 and 4 weeks' injection. PCNA-positive nuclei in group S were significantly less than in group G for only the 1-week injection set ( group G, 2.03 +/- 0.95; group S, 0.85 +/- 1.18 nuclei/ 1 x 10(4) mu m(2)). At 4 weeks, the peritoneal thickness of group S (6.32 +/- 0.53 mu m) was significantly less than that of group G (7.94 +/- 0.77 mu m), There was no significant difference between groups S and A throughout the whole study period except for the result of the number of fibroblast-like cells. Conclusion: These results indicate that a PD solution with a neutral pH and low GDPs proved more biocompatible with the peritoneal membrane than a solution with an acidic pH and high GDPs. Furthermore, the level of the GDPs has more impact on tissue damage of the peritoneal membrane than the pH in the short term. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:E30 / E39
页数:10
相关论文
共 50 条
  • [21] Detection of glucose degradation products in peritoneal dialysis solutions.
    Schalkwijk, CG
    Posthuma, N
    ter Wee, PM
    Teerlink, T
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1627 - 1627
  • [22] Glucose degradation products in peritoneal dialysis:: From bench to bedside
    Jörres, A
    KIDNEY & BLOOD PRESSURE RESEARCH, 2003, 26 (02): : 113 - 117
  • [23] Effects of peritoneal rest on peritoneal transport and peritoneal membrane thickening in continuous ambulatory peritoneal dialysis rats
    Kim, YL
    Kim, SH
    Kim, JH
    Kim, SJ
    Kim, CD
    Cho, DK
    Kim, YJ
    Moberly, JB
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 : S384 - S387
  • [24] Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats
    Musi, B
    Carlsson, O
    Rippe, A
    Wieslander, A
    Rippe, B
    PERITONEAL DIALYSIS INTERNATIONAL, 1998, 18 (03): : 303 - 310
  • [25] Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (balance)
    Lee, HY
    Park, HC
    Seo, BJ
    Do, JY
    Yun, SR
    Song, HY
    Kim, YH
    Kim, YL
    Kim, DJ
    Kim, YS
    Ahn, C
    Kim, MJ
    Shin, SK
    PERITONEAL DIALYSIS INTERNATIONAL, 2005, 25 (03): : 248 - 255
  • [26] Synergistic cytotoxicity of acidity and glucose degradation products in peritoneal dialysis fluid
    Okabe E.
    Tomo T.
    Tezono K.
    Kikuchi H.
    Kadota J.-I.
    Nasu M.
    Journal of Artificial Organs, 2004, 7 (3) : 155 - 160
  • [27] Biological significance of reducing glucose degradation products in peritoneal dialysis fluids
    Wieslander, A
    Linden, T
    Musi, B
    Carlsson, O
    Deppisch, R
    PERITONEAL DIALYSIS INTERNATIONAL, 2000, 20 : S23 - S27
  • [28] Glucose degradation products in peritoneal dialysis fluids: How they can be avoided
    Wieslander, A
    Linden, T
    Kjellstrand, P
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 : S119 - S124
  • [29] Effects of bicarbonate dialysis solution on peritoneal transport in rats
    Suzuki, K
    Khanna, R
    Nolph, KD
    Moore, HL
    Twardowski, ZJ
    ADVANCES IN PERITONEAL DIALYSIS/1996, VOL 12, 1996, 12 : 24 - 26
  • [30] Influence of neutral-pH dialysis solutions on the peritoneal membrane: A long-term investigation in rats
    Wieczorowska-Tobis, K
    Polubinska, A
    Schaub, TP
    Schilling, H
    Wisniewska, J
    Witowski, J
    Passlick-Deetjen, J
    Breborowicz, A
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 : S108 - S113